vimarsana.com

Page 402 - தொழில் முனைவோர் வளர்ச்சி ப்ரோக்ராம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The Evolution of Vape Technology -- A revolution for the E-cig industry inspired by Nikola Tesla

The Evolution of Vape Technology A revolution for the E-cig industry inspired by Nikola Tesla SHENZHEN, China, March 10, 2021 /PRNewswire/ Innokin has teamed up with Fourier Technology to develop the Sensis, the first vaporizer with 4th generation vaping technology. From the first generation Ruyan cigalike to the latest devices, vape technology continues to evolve as improvements in technology and design increase the effectiveness and popularity of vaping. Vaporizer form evolved from cigalike to ego kit, box mod, closed pod, disposable pod to pod mod. However, product form does not go hand in hand with vape technology evolution. First-generation vape technology was basic, where direct power output to the coils could not be adjusted. With the push of a button, or by simply inhaling, the battery heated coils, changing the eliquid into vapour to deliver nicotine and flavours.

Realscreen » Archive » Stephen A Smith, Propagate, Confluential Films team for Black Excellence series

Sports broadcaster and producer Stephen A. Smith, under his new prodco Mr. SAS Productions, has partnered with Propagate Content (Hillary) and Confluential Films (Black Love) on the docuseries Black Excellence. The .

IRICoR, Universit de Montral, IRIC and Valence Discovery collaborate to design novel drug candidates for the treatment of levodopa-induced dyskinesia in Parkinson s disease patients

Published: Mar 10, 2021   A leading researcher at Université de Montréal will leverage IRICoR s expertise in accelerating drug discovery projects and Valence s AI-enabled platform to design highly selective drug candidates against a newly identified target. MONTREAL and CAMBRIDGE, Mass., March 10, 2021 /CNW Telbec/ - IRICoR, a pan-Canadian drug discovery and research commercialization centre, Université de Montréal (UdeM), the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal, and Valence Discovery ( Valence ), an emerging leader in AI-enabled drug design, today announced a collaboration focused on the discovery of novel drug candidates for the treatment of  levodopa-induced dyskinesia in Parkinson s disease.

Fluidra S A : Fluidra Strengthens Industry Leadership Position With Acquisition of Custom Molded Products (CMP)

Fluidra S.A.: Fluidra Strengthens Industry Leadership Position With Acquisition of Custom Molded Products (CMP) Addition of the US manufacturer of pool and spa components will further strengthen Fluidra s leadership position in the pool and wellness industry. CMP s product offering and manufacturing expertise are highly complementary to Fluidra s business, creating expanded growth opportunities and value for customers. The acquisition values CMP at $245 million and is expected to be Cash EPS accretive to Fluidra in 2021. Fluidra S.A. (BME: FDR), the Spanish listed global leader in pool and wellness equipment and connected solutions, today announced it has acquired Custom Molded Products ( CMP ), a Georgia-based manufacturer of pool and spa components, from Tenex Capital Management.

Evelo Biosciences Announces Fourth Quarter and Full Year 2020 Financial Results and Business Highlights

Published: Mar 09, 2021 –Announced new positive data in human experimental model of inflammation of EDP1815– –Completed enrollment in Phase 2b dose-ranging trial for EDP1815 in psoriasis; full data set accelerated and now expected in 3Q 2021– –Initiated Phase 1b clinical trial of EDP1867 in atopic dermatitis; data expected in 4Q 2021– –Up to 8 clinical data readouts expected over next 18 months– –Management to host conference call at 8:30 a.m. ET– CAMBRIDGE, Mass., March 09, 2021 (GLOBE NEWSWIRE) Evelo Biosciences, Inc. (Nasdaq: EVLO), a clinical stage biotechnology company developing a new modality of orally delivered medicines, today reported financial results and business highlights for the fourth quarter and full year 2020.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.